Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Dimas P.Nugraha
Bagian Farmakologi FK UR
Oxytocin
Oxytocin
Mechanisms of Action of
Oxytocin
Secretion of Oxytocin
Stimuli for oxytocin secretion include sensory
stimuli arising from dilation of the cervix and
vagina and from suckling at the breast.
Increases in circulating oxytocin in women in
labor are difficult to detect, partly because of the
pulsatile nature of oxytocin secretion and partly
because of the activity of circulating
oxytocinase.
Increased oxytocin in maternal circulation is
detected in the second stage of labor, likely
triggered by sustained distension of the uterine
cervix and vagina.
Role of oxytocin
Uterus
Stimulates both the frequency and force of uterine
contractility particularly of the fundus segment of
the uterus.
These contractions resemble the normal
physiological contractions of uterus (contractions
followed by relaxation)
Breast
Oxytocin plays an important physiological
role in milk ejection.
Stimulation of the breast through suckling or
mechanical manipulation induces oxytocin
secretion, causing contraction of the
myoepithelium that surrounds alveolar
channels in the mammary gland.
This action forces milk from the alveolar
channels into large collecting sinuses, where
it is available to the suckling infant.
Brain
As noted earlier, oxytocin is
synthesized by hypothalamic
neurons, predominantly located in
the paraventricular and supraoptic
nuclei.
Studies in rodents and humans have
implicated oxytocin as an important
CNS regulator of trust and of
autonomic systems linked to anxiety
Pharmacokinetics of oxytocin
Absorption ,Metabolism and Excretion
Dosis
Dose for Labor Induction
Initial dose: 0.5 to 1 milliunits IV infusion per
hour. At 30 to 60 minute intervals the dose
should be gradually increased in increments
of 1 to 2 milliunits until the desired
contraction pattern has been established.
Postpartum Bleeding
10 to 40 units IV infusion in 1000 mL at a
rate sufficient to control bleeding.
10 units IM after delivery of placenta.
Oxtytocin preparations
Nasal spray
Injection
Indicated only
for pain related
to post partum
breast
engorgement
For induction
of labor
You may not be able to use oxytocin, or you may require a dosage
adjustment or special monitoring during treatment if you have any of the
conditions :
Side effect
Cardiovascular
Cardiovascular side effects have included
hypertension, premature ventricular
contractions, sinus tachycardia, and other
cardiac arrhythmias.
Nervous system
Nervous system side effects have included
mania-like disturbances and seizures. The
seizures may have been related to water
intoxication.
Neonatal seizures and permanent CNS or brain
damage has been reported.
Hypersensitivity
Hypersensitivity side effects have
included anaphylactic reactions.
Genitourinary
Genitourinary side effects have
included pelvic hematoma.
Excessive doses have produced pelvic
fracture, uterine hypertonicity, spasm,
tetanic contraction and rupture.
Hematologic
Hematologic side effects have included
postpartum hemorrhage and fatal
afibrinogenemia.
Hepatic
Hepatic side effects have included neonatal
jaundice.
Gastrointestinal
Gastrointestinal side effects have included
nausea and vomiting.
Respiratory
Respiratory side effects have included
pulmonary edema.
Renal
Renal side effects have included decreases
in glomerular filtration rate and renal
plasma flow.
Doses of 40 milliunits per minute may
produce significant decreases in urine
output.
Ocular
Ocular side effects have included neonatal
retinal hemorrhages.
Psychiatric
Psychiatric side effects have included memory
impairment and mania in patients on high doses.
General
General side effects have include low Apgar
scores at 5 minutes.
Fetal death has been reported.
Contraindications
Abnormal
Prematurity
Hypersensitivity
Evidence
of
fetal
fetal
position
distress
Precautions
a) Multiple pregnancy
b) Previous c- section
c) Hypertension
Ergot Alkaloids
Clinical uses
To Control Postpartum Hemorrhage
to help deliver the placenta
other uterine problems after childbirth.
Side effects
a) Nausea, vomiting, diarrhea
b)
Hypertension
b) Vasoconstriction of peripheral blood
vessels ( toes &
fingers)
c) Gangrene
Contraindications:
Induction of labour
a) 1st and 2nd stage of labor
b) vascular disease
c) Severe hepatic and renal impairment
d) Severe hypertension
PROSTAGLANDINS
(PGE2 & PGF2)
Therapeutic uses
1. Induction of abortion (pathological)**
2. Induction of labor (fetal death in utero)
3. Postpartum hemorrhage
Prostaglandins:
Dinoprostone (PGE2 ),
Action
To promote Ripening and dilatation of the
Cervix prior to labor induction.
With Mifepristone To Terminate Pregnancy
First Trimester.
PGs promote contractility and clear the unborn
fetus.
ADE of PGs:
Uterine Pain,
Nausea, Vomiting, Headache,
Diarrhea (Increased Intestinal Motility).
Rarely ; arrhythmia, hypotension, bronchospasm
Formulations
Cervical gel
Vaginal gel , tab.
Vaginal system ( suppositories )
Oral preparations ??
short-acting (instant-release) preparation (Prostin).
A sustained release preparation of prostaglandin E2
(Propess)
Side Effects
a) Nausea , vomiting
b) Abdominal pain
c) Diarrhea
d) Bronchospasm (PGF2)
e) Flushing (PGE2)
Contraindications:
a) Mechanical obstruction of delivery
b) Fetal distress
c) Predisposition to uterine rupture
Precautions:
a) Asthma
b) Multiple pregnancy
c) Glaucoma
d) Uterine rupture
Oxytocin
Character
Contraction
through out
pregnancy
Only at term
Contraction
Cervix
Difference (contd)
Prostaglandins
Oxytocin
Character
Longer
Shorter
Duration of
action
uses
Oxytocin
Character
Tetanic contraction ;
doesn't resemble
normal physiological
contractions
Resembles normal
physiological
contractions
Contractions
Only in p.partum
hemorrhage
To induce &augment
labor.
*Post partum
hemorrhage
Uses
Moderate onset
Long duration of
action
Rapid onset
Shorter duration of
action
Onset and
Duration
UTERINE RELAXANTS
(Tocolitics)
- adrenoceptor agonists
Mechanism of action
Bind to -adrenoceptors , activate
enzyme Adenylate cyclase , increase in the
level of cAMP reducing intracellular
calcium level.
Side effects:
Tremor
Nausea , vomiting
Flushing
Sweating
Hypotension
Hyperglycemia
Hypokalaemia
Unwanted effects
Headache, dizziness
Hypotension
Flushing
Constipation
Ankle edema
Coughing
Wheezing
Tachycardia
Adverse effects
ulceration
premature closure of ductus arterious.
Atosiban:
Oxytocin R. antagonist
([1-deamino-2-D-Tyro(OEt)-4-Thr-8-Orn]
oxytocin)
is a competitive oxytocin receptor
antagonist.
Terima kasih...